Abstract
Polymer conjugates may possess anticancer activity through a variety of mechanisms. The macro-molecules themselves may have anticancer activities, or, more typically, inert biocompatible polymers serve as carriers for low molecular weight anticancer agents. Polymer conjugates may also be targeted to increase the concentration of conjugate in the vicinity of a specific subset of cells. This article reviews the recent literature that pertains to polymer conjugates with anticancer activity. The types of polymers chosen as drug carriers and the biodistribution of polymers in the body are discussed. Also, the synthesis, biological properties, and the means used to evaluate the anticancer activities of polymer conjugates are detailed.
The rationale for the design of targetable water soluble synthetic polymeric carriers of anticancer drug are explained using copolymers of N-(2-hydroxypropyl)methacrylamide as examples. Comparison of polymer conjugates with other drug delivery systems, i.e., liposomes, nanoparticles, microspheres and immunotoxins, is provided along with the prospects for the future of anticancer drug delivery.
This is a preview of subscription content, log in via an institution.
Preview
Unable to display preview. Download preview PDF.
Abbreviations
- AA:
-
amino acid
- ADEPT:
-
antibody directed enzyme prodrug therapy
- ADR:
-
adriamycin (doxorubicin)
- APA:
-
4-amino-4-deoxy-N 10-methylpteroic acid
- ARS:
-
arsanilic acid
- AZT:
-
azidothymidine
- BOP reagent:
-
benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluorophosphate
- cis-DPP:
-
cis-dichlorodiamminoplatinum (II)
- CEA:
-
carcinoembryonic antigen
- CURL:
-
compartment for uncoupling receptor and ligand
- DMSO:
-
dimethyl sulfoxide
- DNM:
-
daunomycin
- EDTA:
-
ethylene diamine tetraacetic acid
- EEDQ:
-
N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline
- EPR:
-
enhanced permeability and retention effect
- Fab, (Fab)2 :
-
antibody fragments
- FITC:
-
fluorescein isothioisocyanate
- GalN:
-
galactosamine
- HAMA:
-
human anti-mouse antibodies
- hCG:
-
human chorionic gonadotropin
- HPMA:
-
N-(2-hydroxypropyl)methacrylamide
- IgG:
-
immunoglobulin G
- IMC:
-
Institute of Macromolecular Chemistry
- i.p.:
-
intraperitoneal
- i.v.:
-
intravenous
- kcat :
-
catalytic constant
- KM :
-
Michaelis constant
- LCST:
-
lower critical solution temperature
- LHRH:
-
luiteinizing hormone releasing hormone
- MA:
-
methacryloyl
- mAbs:
-
monoclonal antibodies
- Mce6 :
-
meso-chlorin e6 monoethylenediamine disodium salt
- MTT:
-
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide
- MTX:
-
methotrexate
- mPEG:
-
monomethoxypoly(ethylene glycol)
- Mw:
-
molecular weight
- NAp:
-
para-nitroanilide
- OC125:
-
anti-ovarian carcinoma monoclonal antibody
- ONp:
-
para-nitrophenol
- P:
-
polymer backbone
- PDT:
-
photodynamic therapy
- PEG:
-
poly(ethylene glycol)
- PEG-ADA:
-
PEG-adenosine deaminase
- P-D:
-
polymer-drug conjugate
- ⊃—P-D:
-
targeted polymer-drug conjugate
- Pi:
-
enzyme active center subsite
- RES:
-
reticuloendothelial system
- s.c.:
-
subcutaneous
- sFV:
-
single-chain antigen binding proteins
- Si:
-
substrate subsite
- SPDP:
-
N-succinimidyl 3-(2-pyridyldithio)propionate
- sulfo-MBS:
-
m-maleimidobensoyl sulfosuccinimide ester
- TEA:
-
triethylamine
- X:
-
lysosomal enzyme
- ⊥:
-
clathrin molecule
- -●:
-
cell surface receptor/antigen
8 References
Ehrlich P (1906) Studies in immunity. Plenum Press, New York
De Duve C, DeVarsy Th, Poole B, Trouet A, Tulkens P, Van Hoof F (1974) Biochem Pharmacol 23: 2495
Jatzkewitz H (1954) Hoppe-Seyler's Z Physiolog Chem 297: 149
Morell AG, Irvine RA, Sternlieb I, Scheinberg IM, Ashwell G (1968) J Biol Chem 243: 155
Ringsdorf H (1975) J Polym Sci Polym Symp 51: 135
Zee-Cheng RKY, Cheng CC (1989) Meth and Find Exp Clin Pharmacol 11: 439
Papahadjopoulos D, Allen T, Gabizon A, Mayhew E, Matthay K, Huang SK, Lee KD, Woodle MC, Lasic DD, Redemann C, Martin FJ (1991) Proc Natl Acad Sci USA 88: 11460
Couvreur P, Roblot-Treupel L, Poupon MF, Brasseur F, Puisieux F (1990) Adv Drug Deliv Rev 5: 209
Wright JJ Illum L (1992) in: Donbrow M (ed) Microcapsules and nanoparticles in medicine and pharmacy, CRC Press, Boca Raton, p 281
Pastan I, Chaudhary VK, FitzGerald DJ (1992) Ann Rev Biochem 61: 331
Debruyne FM, Denis L, Lunglmeyer G, Mahler C, Newling DW, Richards B (1988) J Urol 140: 775
Krinick NL, Kopeček J (1991) in: Juliano RL (ed) Targeted drug delivery. Springer, Berlin, p 105 (Handbook of experimental pharmacology, Vol 100)
Duncan R (1992) Anti-Cancer Drugs 3: 175
Seymour LW (1992) Crit Rev Ther Drug Carrier Syst 9: 135
Maeda H, Seymour LW, Miyamoto Y (1992) Bioconjugate Chem 3: 351
Sezaki H, Takakura Y, Hashida M (1989) Adv Drug Delivery Rev 3: 247
Hoes CJT, Feijen J (1989) in: Roerdink FDH, Kroon AM (eds) Drug carrier systems, John Wiley, New York, p 57
Kopeček J Duncan R (1987) J Controlled Rel 6: 315
Lloyd JB (1987) in: Johnson P, Lloyd-Jones JG (eds) Drug delivery systems fundamentals, Ellis Horwood, p 95
Duncan R, Kopeček J (1984) Adv Polym Sci 57: 51
Duncan R, Cable HC, Rejmanová P, Kopeček J, Lloyd JB (1984) Biochim Biophys Acta 799: 1
McCormick LA, Seymour LCW, Duncan R, Kopeček J (1986) J Bioact Comp Polym 1: 4
Krinick NL, Říhová B, Ulbrich K, Strohalm J, Kopeček J (1990) Makromol Chem 191: 839
Říhová B Kopečková P, Strohalm J, Rossmann P, Větvička V, Kopeček J (1988) Clin Immunol Immunopathol 46: 100
McGraw TE, Maxfield FR (1991) in: Juliano RL (ed) Targeted drug delivery. Springer, Berlin, p 11 (Handbook of experimental pharmacology, Vol 100)
Kopeček J (1984) Biomaterials 5: 1984
Kopeček J (1990) J Controlled Rel 11: 279
Willner D, Trial PA, Hofstead SJ, King HD, Lasch SJ, Braslawsky GR, Greenfield RS, Kaneko T, Firestone RA (1993) Bioconjugate Chem 4: 521
Shen WC, Ryser HJP (1981) Biochem Biophys Res Commun 102: 1048
Shen WC, Ryser HJP, LaManna L (1985) J Biol Chem 260: 10905
Feener EP, Shen WC, Ryser HJP (1990) J Biol Chem 265: 18780
Thorpe PE, Wallace PM, Knowless PP, Relf MG, Brown ANF, Watson GJ, Knyba RE, Wawrzynczak EJ, Blakey DC (1987) Cancer Res 47: 5924
Goddard P, Petrak K (1989) J Bioact Compat Polym 4: 372
Chiu HC, Kopečková P, Deshmane S, Kopeček J (1994) J Controlled Rel., to be submitted
Chiu HC, Koňák Č, Kopečková P, Kopeček J (1994) J Bioact Compat Polymers, in press
Duncan R, Seymour LW, O'Hare KB, Flanagan PA, Wedge S, Hume IC, Ulbrich K, Strohalm J, Subr V, Spreafico F, Grandi M, Ripamonti M, Farao M, Surato A (1992) J Controlled Rel 19: 331
O'Hare KB, Duncan R, Strohalm J, Ulbrich K, Kopečková P (1993) J Drug Targeting 1: 217
Duncan R, Hume IC, Yardley HJ, Flanagan PA, Ulbrich K, Šubr V, Strohalm J (1991) J Controlled Rel 16: 121
Duncan R, Kopečková-Rejmanová P, Strohalm J, Hume I, Cable HC, Pohl J, Lloyd JB, Kopeček J (1987) Br J Cancer 55: 165
Duncan R, Kopečková P, Strohalm J, Hume IC, Lloyd JB, Kopeček J (1988) Br J Cancer 57: 147
Říhová B, Kopeček J (1985) J Controlled Rel 2: 289
Krinick NL, Sun Y, Joyner D, Spikes JD, Straight RC, Kopeček J (1994) J Biomat Sci Polym Ed., 5: 303
Říhová B, Krinick NL, Kopeček J (1993) J Controlled Rel 25: 71
Hoes CJT, Potman W, van Heeswijk WAR, Mud J, de Grooth BG, Greve J, Feijen J, (1985) J Controlled Rel 2: 205
Hoes CJT, Grootoonk J, Duncan R, Hume IC, Bhakoo M, Bouma JMW, Feijen J, (1993) J Controlled Rel 23: 37
Hurwitz E, Stancovaki I, Wilchek M, Shouval D, Takahashi H, Wands JR, Sela M, (1990) Bioconjugate Chem 1: 285
Abraham A, Nair MG, Kisliuk RL, Gaumont Y, Galivan J (1990) J Med Chem 33: 711
Yokoyama M (1989) PhD Thesis, University of Tokyo p 172
Yokoyama M, Okano T, Sakurai Y, Ekimoto H, Shibazaki C, Kataoka K (1991) Cancer Res 51: 3229
Tanaka T, Kaneo Y, Iguchi S (1991) Bioconjugate Chem 2: 261
Ohkawa K, Hatano T, Tsukada Y, Matsuda M (1993) Br J Cancer 67: 274
Song Y, Onishi H, Nagai T (1993) Biol Pharm Bull 16: 48
Noguchi A, Takahashi T, Yamaguchi T, Kitamura K, Takakura Y, Hashida M, Sezaki H (1992) Bioconjugate Chem 3: 132
Shih LB, Goldenberg DM, Xuan H, Lu H, Sharkey RM, Hall TC (1991) Cancer Res 51: 4192
Trouet A, Jolles G (1984) Seminars in Oncol. 11 (Suppl 3): 64
Oda T, Sato F, Yamamoto H, Akagi M, Maeda H (1989) Anticancer Res 9: 261
Konno T, Maeda H (1987) in: Okada K, Ishak KG (eds) Neoplasma of the Liver, Springer, New York, p 343
Hirano T, Ringsdorf H, Zaharko DS (1980) Cancer Res 40: 2263
Seymour LW (1991) J Bioact Compat Polym 6: 178
Ambrose EJ, Easty DM, Jones PCT (1958) Br J Cancer 12: 439
McGuire JJ, Russell CA (1990) Leukemia 4: 48
Larsen B, Thorling EB (1969) Acta Path Microbiol Scandinav 75: 229
Saiki I, Murata K, Matsuno K, Ogawa R, Nishi N, Tokura S, Azuma I (1990) Jpn J Cancer Res 81: 660
Saiki I, Murata J, Kakajima M, Tokura S, Azuma I (1990) Cancer Res 50: 3631
Zaharko DS, Corey JM (1984) Cancer Treat Rep 68: 1255
Ardalan B, Paget GE (1986) Cancer Res 46: 5473
Rosenblum MG. Hortobagyi GN (1986) Cancer Chemother Pharmacol 18: 247
Bocci V (1987) Pharmac Ther 34: 1
Thomas H (1992) Drugs of today 28: 311
Wada H, Imamura I, Sako M, Katagiri S, Tarui S, Nishimura H, Inada Y (1990) Ann N Y Acad Sci, 613: 95
Fuertges F, Abuchowski A (1990) J Controlled Rel 11: 139
Delgado C, Francis GE, Fisher D (1992) Crit Rev Ther Drug Carrier Syst 9: 249
Katre NV, Knauf MJ, Laird WJ (1987) Proc Natl Acad Sci USA 84: 1487
Chiu HC, Zalipsky S, Kopečková P, Kopeček J (1993) Bioconjugate Chem 4: 290
Wang QC, Pai LH, Debinski W, FitzGerald DJ, Pastan I (1993) Cancer Res 53: 4588
Kyriadikis DA, Tsirka SAE, Tsavdaridis IK, Iliadis SN, Kortsaris AH (1990) Mol Cell Biochem 96: 137
Ashihara Y, Kono T, Yamazaki S, Inada Y (1978) Biochem Biophys Res Comm 83: 385
Hershfield MS, Buckley RH, Greenberg ML, Melton AL, Shiff R, Hatem C, Kurtzberg J, Markert ML, Kobayashi RH, Hobayashi AL, Abuchowski A (1987) N Engl J Med 316: 589
Davis S, Abuchowski A, Park YK, Davis FF (1981) Clin Exp Immunol 46: 649
Beauchamp CO, Gonias SL, Menapace DP, Pizzo SV (1983) Analytical Biochem 131: 25
Pyatak PS, Abuchowski A, Davis FF (1980) Res Comm Chem Pathol Pharmacol 29: 113
Veronese FM, Largajolli R, Boccu E, Banassi CA, Shiavon O (1985) Appl Biochem Biotechnol 11: 141
Nishimura H, Ashihara Y, Matsushima A, Inada Y (1979) Enzyme 24: 261
Katre NV, Knauf MJ, Laird WJ (1987) Proc Natl Acad Sci USA 84: 1487
Rajagopalan S, Gonias SL, Pizzi SV (1985) J Clin Invest 75: 413
Iwashita Y, Yabuki A, Yamaji KY, Iwasaki K, Okami T, Hirata C, Kosaka K (1988) Biomat Art Cells Art Org 16: 271
Tanaka H, Sateke-Ishikawa R, Ishikawa M, Matsuki S, Asano K (1991) Cancer Res 51: 3710
Zalipsky S, Lee C (1992) in: Harris JM (ed) Poly (ethylene glycol) chemistry: Biotechnical and biomedical applications, Plenum, New York, p 347
Ingham KC (1984) Methods Enzymol. 104: 351
Topchieva IN (1980) Russ Chem Rev 49: 260
Andrade JD, Nagaoka S, Cooper S, Okano T, Kim SW (1987) ASAIO J 10: 75
Lee JH, Kopeček J, Andrade JD (1989) J Biomed Mater Res 23: 351
Lee JH, Kopečková P, Kopeček J, Andrade JD (1990) Biomaterials 11: 455
Poznansky MJ, Shandling M, Salkie MA, Elliott, J, Lau E (1982) Cancer Res 42: 1020
Lääne A, Aaviksaar A, Haga M, Chytrý V, Kopeček J (1985) Makromol Chem Suppl 9: 35
Kamei S, Kopeček J (1995) Pharmaceutical Res, in press
Takei YG, Aoki T, Sanui K, Ogata N, Okano T, Sakurai Y (1993) Bioconjugate Chem 4: 42
Takei YG, Aoki T, Sanui K, Ogata N, Okano T, Sakurai Y (1993) Bioconjugate Chem 4: 341
Ito Y, Kotoura M, Chung DJ, Imanishi Y (1993) Bioconjugate Chem 4: 358
Drobník J, Rypáěk F (1984) Adv Polym Sci 57: 1
Drobník, (1989) Adv Drug Deliv Rev 3: 229
Kopeček J (1982) in: Benoit H, Rempp P (eds) IUPAC macromolecules, Pergamon, Oxford. p 305
Kopeček J, Duncan R (1987) in: Illum L, Davis SS (eds) Polymers in controlled drug delivery, John Wright, Bristol, p 152
Joyner WL, Kern DF (1990) Adv Drug Deliv Rev 4: 319
Pitha J (1980) in: Donaruma IG, Ottenbrite RM, Vogl D (eds) Anionic polymeric drugs. Wiley, New York, p 277
Petrak K, Goddard P (1989) Adv Drug Deliv Rev 3: 191
Maeda H, Matsumura Y (1989) Crit Rev Ther Drug Carrier Syst 6: 193
Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF (1983) Science 219: 983
Dvorak HF, Nagy JA, Dvorak JT, Dvorak AM (1988) Am J Pathol 133: 95
Nugent LJ, Jain RK (1984) Am J Physiol 246: H129
Matsumura Y, Maeda H (1986) Cancer Res 6: 6387
Magerstadt M, Antibody conjugates and malignant disease, CRC Press, Boca Raton, FL, 1991
Seymour LW, Duncan R, Kopečková P, Kopeček J (1987) J Bioact Compat Polym 2: 97
Bos E, Boon P, Kaspersen F, McCabe R (1991) J Controlled Rel 16: 101
Flavell DJ, Cooper S, Morland B, French R. Flavell SU (1992) Br J Cancer 65: 545
Fanger MW, Morganelli PM, Guyre PM (1992) Crit Rev Immunol 12: 101
Baxter LT, Jain RK (1991) Microvascular Res 41: 5
Dilman RO (1990) Antibody, Immunoconjug Radiopharm 3: 1
Yokota T, Milenic DE, Whitlow M, Schlom J (1992) Cancer Res 52: 3402
Wright A, Shin SU. Morrison SL (1992) Crit Rev Immunol 12: 125
LoBuglio AF, Wheeler RH, Trang J, Haynes A, Rogers K, Harvey EB, Sun L, Ghrayeb J, Khazaeli MB (1989) Proc Natl Acad Sci USA 86: 4220
Hale G, Clark MR, Marcus R, Winter G, Dyer MJS, Philips JM, Reichmann L, Waldmann H (1988) Lancet p 1394
Trail PA, Willner D, Lasch SJ, Henderson AJ, Hofstead S, Casazza AM, Firestone RA, Hellstrom I, Hellstrom KE (1993) Science 261: 212
Šprincl L, Exner J, Štěrba O, Kopeček J (1976) J Biomed Mater Res 10: 953
Seymour LW, Duncan R, Strohalm J, Kopeček J (1987) J Biomed Mater Res 21: 1341
Arturson G. Granath K, Thoren L, Wallenius G (1964) Acta Chir Scand 127: 543
Yamaoka T, Tabata Y, Ikada Y (1993) Drug Delivery 1: 75
Kopeček J (1981) in: Williams DF (ed) Systemic aspects of biocompatibility, Vol II, CRC Press, Boca Raton, p 159
Hespe W, Meier AM, Blakwater YJ (1977) Drug Res 27: 1158
Takakura Y, Fujita T, Hashida M, Sezaki H (1990) Pharmaceutical Res 7: 339
Duncan R, Pratten MK, Cable HC, Ringsdorf H, Lloyd JB (1981) Biochem J 196: 49
Ulbrich K, Koňák Č, Tuzar Z, Kopeček J (1987) Makromol Chem 188: 1261
Nukui M, Hoes K, van den Berg H, Feijen J (1991) Makromol Chem 192: 2925
Koňák Č, Kopečková P, Kopeček J (1992) Macromolecules 25: 5451
Yokoyama M, Inoue S, Kataoka K, Yui N, Okano T, Sakurai Y, (1989) Makromol Chem 190: 2041
Yokoyama M, Kwon GS, Okano T, Sakurai Y, Ekimoto, Okamoto K, Mashiba H, Seto T, Kataoka K (1993) Drug Delivery 1: 11
Trouet A, Masquelier M, Baurain R, Deprez-de Campeneere D (1982) Proc Natl Acad Sci USA 79: 626
Schechter B, Neumann A, Wilchek M, Arnon R (1989) J Controlled Rel 10: 75
Howe-Grant ME, Lippard SJ (1980) in: Sigel H (ed) Metal ions in biological systems, Vol 11, Marcel Dekker, New York, p 63
Kopeček J (1977) Polymers in Medicine (Wroclaw) 7: 191
Říhová B, Strohalm J, Plocová D, Ulbrich K (1990) J Bioact Compat Polym 5: 249
Obereigner B, Burešová M, Vrána A, Kopeček J (1979) J Polym Sci Polym Symp. 66: 41
Ouchi T, Fujie H, Jokei S, Sakamoto Y. Chikashita H, Inoi T, Vogl O (1986) J Polym Sci Part A: Polym Chem 23: 2059
Ozaki S, Ohnishi J, Watanabe Y, Nohda T, Nagase T, Akiyama T, Uehara N, Hoshi A (1989) Polymer J 21: 955
Giammona G, Giannola LI, Carlisi B, Bajardi ML (1989) Chem, Pharm Bull 37: 2245
Yang F, Zhuo R (1990) Polymer J 22: 572
Zunino F, Pratesi G, Micheloni A (1989) J Controlled Rel 10: 65
Nagy A, Szoke B, Schally AV (1993) Proc Natl Acad Sci USA 90: 6373
Schacht E (1987) in: Illum L, Davis SS (eds) Polymers in drug delivery. Wright, Bristol, p 131
Carlsson J, Drevin H, Axen R (1978) Biochem J 173: 723
Kitagawa T, Shimozono T, Aikawa T, Yoshida T, Nishimura H (1981) Chem Pharm Bull 29: 1130
Kitagawa T, Aikawa T (1976) J Biochem 79: 233
Henkin J (1977) J Biol Chem 252: 4293
Webb RR II, Kancko E (1990) Bioconjugate Chem 1: 96
Vanin EF, Ji TH (1981) Biochemistry 20: 6754
Trommer WE, Kolkenbrock H, Pfleiderer G (1975) Hoppe-Seyler's Z Physiol Chem 356: 1455
Wong SS (1993) Chemistry of protein conjugation and crosslinking, CRC Press, Boca Raton, Florida
Pietersz GA (1990) Bioconjugate Chem 1: 89
Brinckley M (1992) Bioconjugate Chem 3: 2
Persiani S, Yeung A, Shen W-C, Kennedy A (1991) Carcinogenesis 12: 1149
Alam F, Soloway A, Barth RF, Mafune N, Adams DM, Knoth WH (1989) J Med Chem 32: 2326
Chytrý V, Kopeček J, Leibnitz E, O'Hare K, Scarlett L, Duncan R (1987) New Polym Mater 1: 21
Duncan R, Kopeček J, Rejmanová P, Lloyd JB (1983) Biochim Biophys Acta 755: 518
Pietersz GA, Cunningham Z, McKenzie FC (1988) Immunol Cell Biol 66: 43
Rodwell JD, Alvarez VL, Lee C, Lopes AD, Goers JWF, King HD, Powsner HJ, McKearn TJ (1986) Proc Natl Acad Sci USA 83: 2632
O'Shannesy DJ (1990) J Chromatography 510: 13
Mann JS, Huang JC, Keana JFW (1992) Bioconjugate Chem 3: 154
Kato Y, Umemoto N, Kayama Y, Fukushima H, Takeda Y, Hara T, Tsukada Y (1984) J Med Chem 27: 1602
Kopeček J, Rejmanová P, Strohalm J, Ulbrich K, Říhová B, Chytrý V, Lloyd JB, Duncan R (1991) US Patent 5,037,883
Matzku S, Moldenhauer G, Kalthoff H, Canevari S, Colnaghi M, Schuhmacher J, Bihl H (1990) Br J Cancer 62 Suppl X: 1
Bagshawe KD (1989) Br J Cancer 60: 275
Senter PD, Wallace PM, Svensson HP, Vrudhula VM, Kerr DE, Hellstrom I, Hellstrom KE (1993) Bioconjugate Chem 4: 3
Bagshawe KD, Sharma SK, Springer CJ, Antoniw P, Rogers GT, Burke PJ, Melton R, Sherwood R (1991) Antibody Imm Radiopharm 4: 915
Cowan JD, Von Hoff DD (1987), in: Muggia FM, Rozencweig M (eds) Clinical evaluation of antitumor therapy, Nijhoff, Boston, p 33
Sheldon K, Marks A, Baumal R (1989) Anticancer Res 9: 637
Goff BA, Bamberg M, Hasan T (1991) Cancer Res 51: 4762
Říhová B, Bilej M, Větvička V, Ulbrich K, Strohalm J, Kopeček J, Duncan R (1989) Biomaterials 10: 335
Hurwitz E, Kashi R, Arnon R, Wilchek M, Sela M (1985) J Med Chem 28: 137
Smyth MJ, Pietersz GA, McKenzie IFC (1987) Cancer Res 47: 62
Aboud-Pirak E, Hurwitz E, Bellot F, Schlessinger J, Sela M (1989) Proc Natl Acad Sci USA 86: 3778
Dillman RO, Shawler DL, Johnson DE, Meyer DL, Koziol JA, Frincke JM (1986) Cancer Res 46: 4886
Pietersz GA, Smyth MJ, McKenzie IFC (1988) Cancer Res 48: 926
Yeh MY, Roffler SR, Yu MH (1992) Int J Cancer 51: 274
Kanellos J, Pietersz GA, Cunningham Z, McKenzie IFC (1987) Immunol. Cell Biol 65: 483
Kanellos J, Pietersz GA, McKenzie IFC (1985) J Natl Cancer Inst 75: 319
Hurwitz E, Levy R, Maron R, Wilchek M, Arnon R, Sela M (1975) Cancer Res 35: 1175
Mosmann T (1983) J Immunol Methods 65: 55
Slater TF, Sawyer B, Strauli U (1963) Biochim Biophys Acta 77: 383
Shimoyama Y, Kubota T, Watanabe M, Ishibiki K, Abe O (1989) J Surg Oncol 41: 12
Suto A, Kubota T, Shimoyama Y, Ishibiki K, Abe O (1989) J Surg Oncol 42: 28
Krinick NL, Řihová B, Ulbrich K, Andrade JD, Kopeček J (1988) Proc SPIE 997: 70
Kubota T, Yamamoto T, Takahara T, Furukawa T, Ishibiki K, Kitajima M, Shida Y, Nakatsubo H (1992) J Surg Oncol 51: 75
Hoogenboom HR, Raus JCM, Volckaert G (1991) Biochim. Biophys Acta 1096: 345
Roper PR, Drewinko B (1976) Cancer Res 36: 2182
Hamburger AW, Salmon SE (1977) Science 197: 461
Scott Jr. CF, Goldmacher VS, Lambert JM, Jackson JV, Malntyre GD (1987) J Natl Cancer Inst 79: 1163
Rakestraw SL, Ford WE, Tompkins RG, Rodgers MAJ, Thorpe WP, Yarmush ML (1992) Biotechnol Prog 8: 30
Oseroff AR, Ohuoha D, Hasan T, Bommer JC, Yarmush ML (1986) Proc Natl Acad Sci USA 83: 8744
Triton TR, Yee G (1982) Science 217: 248
Hirano T, Ohashi S, Morimoto S, Tsuda K, Kobayashi T, Tsukagoshi S (1986) Makromol Chem 187: 2815
Jones KH, Senft JA (1985) J Histochem Cytochem 33: 77
Altman SA, Randers L. Rao G (1993) Biotechnol Prog 9: 671
Endo N, Takeda Y, Umemoto N, Kishida K, Watanabe K, Saito M, Kato Y, Hara T (1988) Cancer Res 48: 3330
Umemoto N, Kato Y, Endo N, Takeda Y, Hara T (1989) Int J Cancer 43: 677
Ovadia M, Hager CC, Oeltmann TN (1990) Anticancer Res 10: 671
Youle RJ, Neville Jr, DM (1980) Proc Natl Acad Sci USA 77: 5483
Kopeček J, Šprinct L (1974) Polymers in Medicine (Wroclaw) 4: 109
Teece R, Fraioli R, De Fabritis P, Sandrelli A, Savarese A, Santoro L, Cuomo M, Natali PG, (1991) Int J Cancer 49: 310
Brooks CG, Rees RC, Robins RA (1978) J Immunol Meth 21: 111
Van Putten LM (1987), in: Muggia FM, Rozencweig M (eds) Clinical evaluation of antitumor therapy, Nijhoff, Boston p 17
Ueda Y, Munechika K, Kikukawa A, Kanoh Y, Yamanouchi K, Yokoyama K (1989) Chem Pharm Bull 37: 1639
Goldin A (1966) Cancer Chemotherapy Reports 50: 173
Ohya Y, Huang TZ, Ouchi T, Hasegawa K, Tamura J, Kadowaki K, Matsumoto T, Suzuki S, Suzuki M (1991) J Controlled Rel 17: 259
Zunino F, Giuliani F, Saui G, Dasdia T, Gambetta R (1982) Int J Cancer 30: 465
Pratesi G, Savi G, Pezzoni G, Bellini O, Penco S, Tinelli S, Zunino F (1985) Br J Cancer 52: 841
Meyer RM, Quirt IC, Skillings JR, Cripps MC, Bramwell VHC, Weinerman BH, Gospodarowitz MK, Burns BF, Sargeant AM Shepherd LE, Zee, B. Hryniuk WM (1993) N Engl J Med 329: 1770
Bernstein A, Hurwitz E, Maron R, Arnon R. Sela M, Wilchek M (1978) J Natl Cancer Inst 60: 379
Flanagan PA, Duncan R, Říhová B, Šubr V, Kopeček J (1990) J Bioact Compat Polym 5: 151
Maeda H, Matsumoto T, Konno T, Iwai K, Ueda M (1984) J Protein Chem 3: 181
Meijer DKF, Jansen RW, Pauwels R, Schols D, de Clercq E (1992) 2nd Eur Symp on Controlled Drug Delivery, Noordwijk aan Zee, The Netherlands, April 1–3, Abstracts p 167
Meijer DKF, Jansen RW, Molema G (1992) Antiviral Res 18: 215
Myers KJ, Ron Y (1992) Pharmaceutical Technology p 26 (January)
Sung C, Shockley TR, Morrison PF, Dvorak HF, Yarmush ML, Dedrick RL (1992) Cancer Res 52: 377
Anderson DC, Manger R, Schroeder J, Woodle D, Barry M, Morgan AC, Fritzberg AR (1993) Bioconjugate Chem 4: 10
Wichterle O, Lim D (1960) Nature 185: 117
Wichterle O (1968) US Patent 3,361, 858
Šprincl L, Vacík J, Kopeček J, Lím D (1971) J Biomed Mater Res 5: 197
Šprincl L, Vacík J, Kopeček J (1973) J Biomed Mater Res 7: 123
Kopeček J, Šprincl L, Bažilová H, Vacík J (1973) J Biomed Mater Res 7: 111
Šprincl L, Kopeček J, Lím D (1973) Calc Tissue Res 13: 63
Kopeček J, Šprincl L, Lím D (1973) J Biomed Mater Res 7: 179
Voldřich Z, Tománek Z, Vacík, J Kopeček J (1975) J Biomed Mater Res 9: 675
Kopeček J, Bažilová H (1973) Europ. Polym J 9: 7
Bohdanecký M, Bažilová H, Kopeček J (1974) Europ Polym J 10: 405
Drobník J, Kopeček J, Labský J, Rejmanová P, Exner J, Saudek, V, Kálal J (1976) Makromol Chem 177: 2833
Kopeček J, Cífková I, Rejmanová P, Strohalm J, Obereigner B, Ulbrich K (1981) Makromol Chem 182: 2941
Rejmanová P, Labský J, Kopeček J (1977) Makromol Chem 178: 2159
Kopeček J (1977) Makromol Chem 178: 2169
Kopeček J, Rejmanová P (1979) J Polym Sci Poly Symp 66: 15
Chytrý V, Vrána A, Kopeček J (1978) Makromol Chem 179: 329
Solovskij MV, Ulbrich K, Kopeček J (1983) Biomaterials 4: 44
Schechter I, Berger A (1967) Bichem Biophys Res Commun 27: 157
Kopeček J, Rejmanová P, Chytrý V (1981) Makromol Chem 182: 799
Rejmanová P, Obereigner B, Kopeček J (1981) Makromol Chem 182: 1899
Ulbrich K, Strohalm J, Kopeček J (1981) Makromol Chem 182: 1917
Ulbrich K, Zacharieva EI, Obereigner B, Kopeček J (1980) Biomaterials 1: 199
Duncan R, Cable HC, Lloyd JB, Rejmanová P, Kopeček J (1982) Biosci Rep 2: 1041
Duncan R, Cable HC, Lloyd JB, Rejmanová P, Kopeček J (1983) Makromol Chem 184: 1997
Rejmanová P, Pohl J, Baudyš M, Kostka V, Kopeček J (1983) Makromol Chem 184: 2009
Šubr V, Kopeček J, Pohl J, Baudyš M, Kostka V (1988) J Controlled Rel 9: 133
RejmanovSLAYER P, Kopeček J, Duncan R, Lloyd JB (1985) Biomaterials 6: 45
Kopeček J, Rejmanová P, Duncan R, Llyod JB (1985) Ann N Y Acad Sci 446: 93
Kopeček J (1987) Proc Intern Symp Control Rel Bioactive Mater 14: 125
Blow DM (1974) Bayer Symp 5: 473
Ulbrich K, Strohalm J, Kopeček J (1986) Makromol Chem 187: 1131
Musil D, Zucic D, Turk D, Engh RA, Mayr I, Huber R, Popovic T, Turk V, Towatari T, Katunuma N, Bode W (1991) EMBO J 10: 2321
Yamamoto A, Kaji T, Tomoo K, Ishida T, Inoue M, Murata M, Kitamura K (1992) J Mol Biol 227: 942
Van den Hamer CJA, Morell AG, Scheiberg IH, Hickman J, Ashwell G (1970) J Biol Chem 245: 4397
Ashwell G, Harford J (1982) Annu Rev Biochem 51: 531
Duncan R, Lloyd JB, Rejmanová P, Kopeček J (1985) Makromol Chem Suppl 9: 3
Duncan R, Seymour LCW, Scarlett L, Lloyd JB, Rejmanová P, Kopeček J (1986) Biochim Biophys Acta 880: 62
Wedge SR, Duncan R, Kopečková P (1991) Br J Cancer 63: 546
Omelyanenko V, Kopečková P, Rathi RC, Kopeček J (1994) Biochim Biophys Acta to be submitted
Duncan R, Hume IC, Kopečková P, Ulbrich K, Strohalm J, Kopeček J (1989) J Controlled Rel 10: 51
Seymour L, Ulbrich K, Wedge SR, Hume IC, Strohalm J, Duncan R (1991) Br J Cancer 63: 859
Cartlidge SA, Duncan R, Llyod JB, Rejmanová P, Kopeček J (1986) J Controlled Rel 3: 55
Goddard P, Williamson I, Brown J, Hutchinson LE, Nicholls J, Petrak K (1991) J Bioact Compat Polym 6: 4
Cartlidge SA, Duncan R, Lloyd JB, Kopečková-Rejmanová P, Kopeček J (1987) J Controlled Rel 4: 253
Ambler LE, Brookman L, Brown J, Goddard P, Petrak K (1992) J Bioact Compat Polym 7: 233
Cartlidge SA, Duncan R, Lloyd JB, Kopečková-Rejmanová P, Kopeček J (1987) J Controlled Rel 4: 265
Ulbrich K, Zacharieva EI, Kopeček, J Hume IC, Duncan R (1987) Makromol Chem 188: 2497
O'Hare KB, Hume IC, Scarlett L, Chytrý V, Kopečková P, Kopeček J, Duncan R (1989) Hepatology 10: 207
Říhová B, Kopeček J, Kopečková-RejmanoSLAYER P, Strohalm J, Plocová D, Semorádová H (1986) J Chromatogr Biomed Appl 376: 221
Říhová B, Větvička V, Strohalm J, Ulbrich K, Kopeček J (1989) J Controlled Rel 9: 21
Říhová B, Vereš V, Fornüsek L, Ulbrich K, Strohalm J, Větvička V, Bilej M, Kopeček J (1989) J Controlled Rel 10: 37
Seymour LW, Flanagan PA, Al-Shamkani A, Subr V, Ulbrich K, Cassidy J, Duncan R (1991) Select. Cancer Therapeut 7: 59
Flanagan PA, Kopečková P, Kopeček J, Duncan R (1989) Biochim Biophys Acta 993: 83
Krinick NL, Combination polymeric drugs as anticancer agents, Ph D Thesis, University of Utah, 1992
Kopeček J, Krinick NL (1993) US Patent 5,258,453
Štěrba O. Paluska E, Jozová O, Špunda J, Nezvalová J, Šprincl L, Kopeček J, Činátl J (1975) Čas Lék Českých 114: 1268
Korčáková L, Paluska E, Hašková V, Kopeček J (1976) Z. Immun Forsch 151: 219
Paluska E, Činátl J, Korčáková L, Štěrba O, Kopeček J, Hrubá A, Nezvalová j, Staněk R (1980) Folia biologica (Prague) 26: 304
Štěeba O, Uhlířová Z, Petz R, Viktora L, Jirásek A, Kopeček J (1980) Čas Lék. Českých 119: 994
Činátl J, Štěrba O, Paluska E, Polednová V, Kopeček J (1980) Čs Farmacie 29: 134
Paluska E, Hrubá A, Štěrba O, Kopeček J (1986) Folia Biologica (Prague) 32: 91
Říhová B, Kopeček J, Ulbrich K, Pospíšil M, Mančal P (1984) Biomaterials 5: 143
Říhová B, Ulbrich K, Kopeček J, Mančal P (1983) Foila Microbiologica (Prague) 28: 217
Řihová B, Kopeček J, Ulbrich K, Chytrý V (1985) Makromol Chem Suppl 9: 13
Tlaskalová-Hogenová H, Kopeček J, Ulbrich K, RySLAYERaček F, Pospíšil M (1985) Makromol Chem Suppl 9: 137
Šimečková J, Říhová B, Plocová D, Kopeček J (1986) J Bioact Compact Polym 1: 20
Yeung TK, Hopewell JW, Simmonds RH, Seymour LW, Duncan R, Bellini O, Grandi M, Spreafico F, Strohalm J, Ulbrich K (1991) Cancer Chemother Pharmacol 29: 105
Seymour LW, Ulbrich K, Strohalm J, Kopeček J, Duncan R (1990) Biochem Pharmacol. 39: 1125
Gu ZW, Spikes JD, Kopečková P, Kopeček J (1993) Collect Czech Chem Commun 58: 2321
Bayley H, Gasparro F, Edelson R (1987) Trends Pharmacol Sci 8: 138
Cassidy J, Duncan R, Morrison GJ, Strohalm J, Plocová D, Kopeček J, Kaye SB (1989) Biochem Pharmacol 38: 875
Gomer CJ, Rucker N, Ferratio A, Wong S (1989) Radiat Res 120: 1
Henderson BW, Dougherty TJ (1992) Photochem Photobiol 55: 145
Spikes JD (1989) in: Smith KC (ed) The science of photobiology, 2nd ed., Plenum New York, p. 79
Kopeček J, Říhová B, Krinick NL (1991) J Controlled Rel 16: 137
Kopeček J, (1991) Ann N Y Acad Sci 618: 335
Jiang FN, Allison B, Liu D, Levy JG (1992) J Controlled Rel 19: 41
Wöhrle D, Krawczyk G, Paliuras M (1988) Makromol Chem 189: 1013
Peterson MC et al. (1994) in preparation
Sata T (1990) Polysaccharide coated liposomes, Ph D Thesis, University of Nagasaki
Gregoriadis G (1993) Liposome technology, Vol I–III, 2nd ed., CRC Press, Boca Raton, FL
Nässander UK (1991) Liposomes, immunoliposomes, and ovarian carcinoma, PhD Thesis, Unviersity of Utrecht
Connor J Huang L (1986) Cancer Res 46: 3431
Maeda M, Kumano A, Tirrell DA (1991) Ann New York Acad Sci 618: 362
Weinstein JN, Magin RL, Cysyk RL, Zaharko DS (1980) Cancer Res 40: 1388
Zou Y, Yamagishi M, Horikoshi I, Ueno M, Gu X, Perez-Soler R (1993) Cancer Res 53: 3046
Senior J (1987) Crit Rev Ther, Drug Carrier Syst 3: 123
Becker S (1988) Adv Drug Deliv Rev 3: 1
Alving CR (1988) Adv Drug Deliv Rev 2: 107
Lopez-Berenstein G, Fainstein V, Hopfer R, Mehta K, Sullivan MP, Keating M, Rosenblum MG, Mehta R, Luna M, Hersh EM, Reuben J, Juliano RL, Bodey GP (1985) J Infect Dis 150: 278
Sculier JP, Coune A, Meunier F, Brassine C, Laduron C, Hollaert C, Collete N, Heymans C, Klastersky J (1988) Eur J Cancer Clin Oncol 24: 527
Sunamoto J, Iwamoto K (1986) Crit Rev Ther Drug Carrier Syst 2: 117
Peeters PAM, Storm G, Crommelin DJA (1987) Adv Drug Deliv Rev 1: 249
Allen TM, Mehra T, Hansen C, Chin YC (1992) Cancer Res 52: 2431
Allen TM (1993) NATO ASI “Targeting of Drugs: Advances in Systems Constructs”, Cape Sounion Beach, Greece, June 24–July 5, 1993, Abstracts
Torchilin VP, Trubetskoy VS, Papisov MI, Bogdanov AA, Omelyanenko VG, Narula J, Khaw BA (1993) Proc Intern Symp Control Rel Bioact Mater 20: 194
Cowens JW, Creaven PJ, Greco WR, Brenner DE, Tung Y, Ostro M, Pilkiewicz F. Ginsberg R, Petrelli N (1993) Cancer Res 53: 2796
Nabel GJ, Nabel EG, Yang ZY, Fox BA, Plautz GE, Gao X, Huang L, Shu S, Gordon D. Chang AE (1993) Proc Natl Acad Sci USA 90: 11307
Douglas SJ, Davis SS, Illum L (1987) Crit Rev Ther Drug Carrier Syst 3: 233
Couvreur P, Vauthier C (1991) J Controlled Rel 17: 187
Birrenbach G, Speiser P (1976) J Pharm Sci 65: 1763
Kreuter J, Speiser P (1976) J Pharm Sci 65: 1424
Lenaerts V, Couvreur P, Christiaens-Leyh D, Joiris E, Roland M, Rollman B, Speiser P (1984) Biomaterials 5: 65
Verdun C, Brasseur F, Vranckx H, Couvreur P, Roland M (1990) Cancer Chemother Pharmacol 26: 13
Illum L, Jones PDE, Baldwin RW, Davis SS (1984) J Pharmacol Exp Ther 230: 733
Douglas SJ, Davis SS, Illum L (1986) Int J Pharm 34: 145
Müller BG, Kissel T (1993) Pharm Pharmacol Lett 3: 67
Donbrow M (1992) Microcapsules and nanoparticles in medicine and pharmacy, CRC Press, Boca Raton, FL
Pfeifle CE, Howell SB, Ashburn WL, Barone RM, Bookstein JJ (1986) Cancer Drug Deliv 3: 1
Edman P, Sjöholm I (1992) in: Donbrow M (ed) Microcapsules and nanoparticles in medicine and pharmacy, CRC Press, Boca Raton, FL, p 265
Juliano RL (1988) Adv Drug Del Rev 2: 31
Illum L, Davis SS (1984) FEBS Lett 167: 79
Illum L, Davis SS, Muller RH, Mak E, West P (1987) Life Sci 40: 367
Illum L, Davis SS (1987) Life Sci 40: 1553
Moghimi SM, Illum L, Davis SS (1990) Crit Rev Ther Drug Carrier Syst 7: 187
Harper GR, Davies MC, Davis SS, Tadros ThF, Taylor DC, Irving MP, Waters JA (1991) Biomaterials 12: 695
Okada H, Heya T, Ogawa Y, Shimamoto T (1988) J Pharmacol Exp Therap 244: 744
Ogawa Y, Okada H, Heya T, Shimamoto T (1989) J Pharm Pharmacol 41: 439
Okada H, Inoue Y, Heya T, Ueno H, Ogawa Y, Toguchi H (1991) Pharmaceutical Res 8: 787
Řihová B, Jegorov A, Strohalm J, Matha V, Rossmann, P, Fornůsek L, Ulbrich K (1992) J Controlled Rel 19: 25
Ogawa Y, Yamamoto M, Takada S, Okada H, Shimamoto T (1988) Chem Pharm Bull 36: 1502
Neville Jr DM, Scharff J, Srinivasachar K (1993) J Controlled Rel 24: 133
Sung C, Wilson D, Youle RJ (1991) J Biol Chem 266: 14159
FitzGerald D, Pastan I (1989) J Natl Cancer Inst 81: 1455
Wawrzynczak EJ (1991) Br J Cancer 64: 624
Byers VS, Rodvien R, Grant K, Durrant LG, Hudson KH, Baldwin RW, Scannon PJ (1989) Cancer Res 49: 6153
Vitetta ES, Stone M, Amlot P, Fay J, May R, Till M, Newman J, Clark P, Cunningham D, Ghetie V, Uhr JW, Thorpe PE (1991) Cancer Res 51: 4052
Oratz R, Speyer JL, Wernz JC, Hochster H, Meyers M, Mischak R, Spitler LE (1990) J Biol Respond Mod 9: 345
Kreitman RJ, FitzGerald D, Pastan I (1992) Int J Immunopharmac 14: 465
Pastan I, FitzGerald DJ (1991) Science 254: 1173
FitzGerald D, Pastan I (1993) NATO ASI “Targeting of Drugs: Advances in Systems Constructs”, Cape Sounion Beach, Greece June 24 — July 5, 1993, Abstracts
Hinman LM, Hamann PR, Wallace R, Menendez AT, Durr FE, Upeslacis J (1993) Cancer Res 53: 3336
Chari RVJ, Martell BA, Gross JL, Cook SB, Shah SA, Blättler WA, McKenzie SJ, Goldmacher VS (1992) Cancer Res 52: 127
Lee MD, Dunne TS, Chang CC, Siegal MM, Morton GO, Ellestad GA, McGahren WJ, Borders DB (1992) J Am Chem Soc 114: 985
Anderson WF (1994) Human Gene Therapy 5: 1
Degols G, Machy P, Leonetti JP, Leserman L, Lebleu B (1992) in: Murray JAH (ed) Antisense RNA and DNA, Wiley-Liss, New York, p 255
Stein CA, Cheng YC (1993) Science 261: 1004
Bunnell BA, Askari FK, Wilson JM (1992) Somat Cell Mol Genet 18: 559
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 1995 Springer-Verlag
About this paper
Cite this paper
Putnam, D., Kopeček, J. (1995). Polymer conjugates with anticancer activity. In: Peppas, N.A., Langer, R.S. (eds) Biopolymers II. Advances in Polymer Science, vol 122. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3540587888_14
Download citation
DOI: https://doi.org/10.1007/3540587888_14
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-58788-0
Online ISBN: 978-3-540-49102-6
eBook Packages: Springer Book Archive